Relay Therapeutics, Inc.RLAYNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-1777.41%
↑ 61% vs avg
Percentile
P43
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-4585.87%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -1777.41% | +53.2% |
| 2024 | -3799.44% | -159.4% |
| 2023 | -1464.62% | +93.4% |
| 2022 | -22217.38% | -201.7% |
| 2021 | -7364.87% | -11551.1% |
| 2020 | -63.21% | - |
| 2019 | 0.00% | - |
| 2018 | 0.00% | - |